Your browser doesn't support javascript.
loading
Maternal and fetal genetic contribution to gestational weight gain.
Warrington, N M; Richmond, R; Fenstra, B; Myhre, R; Gaillard, R; Paternoster, L; Wang, C A; Beaumont, R N; Das, S; Murcia, M; Barton, S J; Espinosa, A; Thiering, E; Atalay, M; Pitkänen, N; Ntalla, I; Jonsson, A E; Freathy, R; Karhunen, V; Tiesler, C M T; Allard, C; Crawford, A; Ring, S M; Melbye, M; Magnus, P; Rivadeneira, F; Skotte, L; Hansen, T; Marsh, J; Guxens, M; Holloway, J W; Grallert, H; Jaddoe, V W V; Lowe, W L; Roumeliotaki, T; Hattersley, A T; Lindi, V; Pahkala, K; Panoutsopoulou, K; Standl, M; Flexeder, C; Bouchard, L; Aagaard Nohr, E; Marina, L Santa; Kogevinas, M; Niinikoski, H; Dedoussis, G; Heinrich, J; Reynolds, R M; Lakka, T.
Afiliação
  • Warrington NM; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.
  • Richmond R; Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.
  • Fenstra B; Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Myhre R; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Gaillard R; Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark.
  • Paternoster L; Norwegian Institute of Public Health, Oslo, Norway.
  • Wang CA; The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Beaumont RN; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Das S; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Murcia M; Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Barton SJ; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Espinosa A; Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.
  • Thiering E; Institute of Biomedical and Clinical Science, University of Exeter Medical School, University of Exeter, Royal Devon and Exeter Hospital, Exeter, UK.
  • Atalay M; Department of Public Health and Primary Care, School of Public Health, Imperial College London, London, UK.
  • Pitkänen N; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain.
  • Ntalla I; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain.
  • Jonsson AE; MRC Lifecourse Epidemiology Unit, Faulty of Medicine, University of Southampton, Southampton, UK.
  • Freathy R; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain.
  • Karhunen V; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Tiesler CMT; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Allard C; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Crawford A; Institute of Epidemiology I, Helmholtz Zentrum München- German Research Center for Environmental Health, Neuherberg, Germany.
  • Ring SM; Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, University of Munich Medical Center, Munich, Germany.
  • Melbye M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Magnus P; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Rivadeneira F; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Skotte L; The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, and Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hansen T; Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Marsh J; Institute of Biomedical and Clinical Science, University of Exeter Medical School, University of Exeter, Royal Devon and Exeter Hospital, Exeter, UK.
  • Guxens M; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Holloway JW; Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Grallert H; Institute of Epidemiology I, Helmholtz Zentrum München- German Research Center for Environmental Health, Neuherberg, Germany.
  • Jaddoe VWV; Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, University of Munich Medical Center, Munich, Germany.
  • Lowe WL; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada.
  • Roumeliotaki T; Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Hattersley AT; British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Lindi V; Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Pahkala K; ALSPAC (Children of the 90s), School of Social and Community Medicine, University of Bristol, Bristol, UK.
  • Panoutsopoulou K; Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark.
  • Standl M; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
  • Flexeder C; Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.
  • Bouchard L; Norwegian Institute of Public Health, Oslo, Norway.
  • Aagaard Nohr E; The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Marina LS; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kogevinas M; Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Niinikoski H; Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark.
  • Dedoussis G; The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, and Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Heinrich J; Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.
  • Reynolds RM; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain.
  • Lakka T; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Int J Obes (Lond) ; 42(4): 775-784, 2018 04.
Article em En | MEDLINE | ID: mdl-28990592
ABSTRACT

BACKGROUND:

Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG. PARTICIPANTS AND

METHODS:

A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (for example, maternal body mass index (BMI) and glucose, birth weight).

RESULTS:

Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-specific beta-1 glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 × 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birth weight variants were largely unrelated to GWG.

CONCLUSIONS:

We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gravidez / Feto / Ganho de Peso na Gestação Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Int J Obes (Lond) Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gravidez / Feto / Ganho de Peso na Gestação Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Int J Obes (Lond) Ano de publicação: 2018 Tipo de documento: Article